通过整合渗透泵和磁性纳米颗粒,实现可控给药系统的新应用。

IF 3.4 3区 综合性期刊 Q2 CHEMISTRY, ANALYTICAL
Sensors Pub Date : 2024-10-31 DOI:10.3390/s24217042
David Navarro-Tumar, Belén García-Merino, Cristina González-Fernández, Inmaculada Ortiz, Ma-Fresnedo San-Román, Eugenio Bringas
{"title":"通过整合渗透泵和磁性纳米颗粒,实现可控给药系统的新应用。","authors":"David Navarro-Tumar, Belén García-Merino, Cristina González-Fernández, Inmaculada Ortiz, Ma-Fresnedo San-Román, Eugenio Bringas","doi":"10.3390/s24217042","DOIUrl":null,"url":null,"abstract":"<p><p>The alarming rise in chronic diseases worldwide highlights the urgent need to overcome the limitations of conventional drug delivery systems. In this context, osmotic pumps are able to release drugs by differential osmotic pressure, achieving a controlled rate independent of physiological factors and reducing the dosing frequency. As osmotic pumps are based on the phenomenon of osmosis, the choice of high osmolality draw solutions (DSs) is a critical factor in the successful delivery of the target drug. Therefore, one alternative that has received particular attention is the formulation of DSs with magnetic nanoparticles (MNPs) due to their easy recovery, negligible reverse solute flux (RSF), and their possible tailor-made functionalization to generate high osmotic gradients. In this work, the possible integration of DSs formulated with MNPs in controlled drug delivery systems is discussed for the first time. In particular, the main potential advantages that these novel medical devices could offer, including improved scalability, regeneration, reliability, and enhanced drug delivery performance, are provided and discussed. Thus, the results of this review may demonstrate the potential of MNPs as osmotic agents, which could be useful for advancing the design of osmotic pump-based drug delivery systems.</p>","PeriodicalId":21698,"journal":{"name":"Sensors","volume":"24 21","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548579/pdf/","citationCount":"0","resultStr":"{\"title\":\"Novel Applications in Controlled Drug Delivery Systems by Integrating Osmotic Pumps and Magnetic Nanoparticles.\",\"authors\":\"David Navarro-Tumar, Belén García-Merino, Cristina González-Fernández, Inmaculada Ortiz, Ma-Fresnedo San-Román, Eugenio Bringas\",\"doi\":\"10.3390/s24217042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The alarming rise in chronic diseases worldwide highlights the urgent need to overcome the limitations of conventional drug delivery systems. In this context, osmotic pumps are able to release drugs by differential osmotic pressure, achieving a controlled rate independent of physiological factors and reducing the dosing frequency. As osmotic pumps are based on the phenomenon of osmosis, the choice of high osmolality draw solutions (DSs) is a critical factor in the successful delivery of the target drug. Therefore, one alternative that has received particular attention is the formulation of DSs with magnetic nanoparticles (MNPs) due to their easy recovery, negligible reverse solute flux (RSF), and their possible tailor-made functionalization to generate high osmotic gradients. In this work, the possible integration of DSs formulated with MNPs in controlled drug delivery systems is discussed for the first time. In particular, the main potential advantages that these novel medical devices could offer, including improved scalability, regeneration, reliability, and enhanced drug delivery performance, are provided and discussed. Thus, the results of this review may demonstrate the potential of MNPs as osmotic agents, which could be useful for advancing the design of osmotic pump-based drug delivery systems.</p>\",\"PeriodicalId\":21698,\"journal\":{\"name\":\"Sensors\",\"volume\":\"24 21\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548579/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sensors\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.3390/s24217042\",\"RegionNum\":3,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sensors","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.3390/s24217042","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

摘要

全球慢性病发病率的惊人增长凸显了克服传统给药系统局限性的迫切需要。在这种情况下,渗透泵能够通过渗透压差释放药物,实现不受生理因素影响的可控速率,并减少给药频率。由于渗透泵以渗透现象为基础,因此选择高渗透压吸取溶液(DSs)是成功输送目标药物的关键因素。因此,磁性纳米粒子(MNPs)是一种备受关注的替代方案,因为它们易于回收、反向溶质通量(RSF)可忽略不计,而且可以进行定制功能化以产生高渗透梯度。在这项研究中,我们首次讨论了在可控给药系统中使用 MNPs 配制 DSs 的可能性。特别是,本文提供并讨论了这些新型医疗器械可能带来的主要潜在优势,包括更好的可扩展性、再生性、可靠性和更强的给药性能。因此,本综述的结果可能会证明 MNPs 作为渗透剂的潜力,这对推进基于渗透泵的给药系统的设计可能很有帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Novel Applications in Controlled Drug Delivery Systems by Integrating Osmotic Pumps and Magnetic Nanoparticles.

The alarming rise in chronic diseases worldwide highlights the urgent need to overcome the limitations of conventional drug delivery systems. In this context, osmotic pumps are able to release drugs by differential osmotic pressure, achieving a controlled rate independent of physiological factors and reducing the dosing frequency. As osmotic pumps are based on the phenomenon of osmosis, the choice of high osmolality draw solutions (DSs) is a critical factor in the successful delivery of the target drug. Therefore, one alternative that has received particular attention is the formulation of DSs with magnetic nanoparticles (MNPs) due to their easy recovery, negligible reverse solute flux (RSF), and their possible tailor-made functionalization to generate high osmotic gradients. In this work, the possible integration of DSs formulated with MNPs in controlled drug delivery systems is discussed for the first time. In particular, the main potential advantages that these novel medical devices could offer, including improved scalability, regeneration, reliability, and enhanced drug delivery performance, are provided and discussed. Thus, the results of this review may demonstrate the potential of MNPs as osmotic agents, which could be useful for advancing the design of osmotic pump-based drug delivery systems.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sensors
Sensors 工程技术-电化学
CiteScore
7.30
自引率
12.80%
发文量
8430
审稿时长
1.7 months
期刊介绍: Sensors (ISSN 1424-8220) provides an advanced forum for the science and technology of sensors and biosensors. It publishes reviews (including comprehensive reviews on the complete sensors products), regular research papers and short notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信